Literature DB >> 8972663

Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94.

S V Nielsen1, J Henrichsen.   

Abstract

During the period 1989-94, 4620 strains of Streptococcus pneumoniae (4063 from blood and 557 from cerebrospinal fluid), from cases of invasive disease in Denmark, were received for capsular typing and penicillin susceptibility testing. During the study period the incidence of bacteraemic pneumococcal disease increased from 10 to 18 cases per 100000 inhabitants per year. The highest rates were seen in the very young, age less than 5 years (23/100000/year, in 1994), and in the elderly, age greater than 60 years (55/100000/year, in 1994). The annual number of cases of meningitis did not vary. Overall, 92% (93% blood, 87% CSF) of isolates and 94% of all childhood isolates belonged to the 23 vaccine types. The capsular types occurring most commonly among the 4123 pneumococcal strains from adults were types 1, 4, 14, 6A + 6B, 7F, 9V, 3, 12F, and 8 (in order of frequency). The ten most frequently occurring types from children (6A + 6B, 18C, 14, 1, 7F, 19F, 9V, 4, and 23F) covered 84% of the cases of bacteraemia and meningitis. Reduced susceptibility to penicillin was rare (< 1%).

Entities:  

Mesh:

Year:  1996        PMID: 8972663      PMCID: PMC2271638          DOI: 10.1017/s0950268800059057

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  25 in total

1.  Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis.

Authors:  R Munoz; J M Musser; M Crain; D E Briles; A Marton; A J Parkinson; U Sorensen; A Tomasz
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

2.  Developing and deploying pneumococcal and haemophilus vaccines.

Authors:  M C Steinhoff
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

Review 3.  Antimicrobial resistance in Streptococcus pneumoniae: an overview.

Authors:  P C Appelbaum
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

4.  The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990--ethnic differences and opportunities for prevention.

Authors:  M Davidson; A J Parkinson; L R Bulkow; M A Fitzgerald; H V Peters; D J Parks
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

5.  Streptococcus pneumoniae type 16A, a hitherto undescribed pneumococcal type.

Authors:  R Austrian; C Boettger; M Dole; L Fairly; M Freid
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

6.  Serotypes responsible for invasive Streptococcus pneumoniae infections among children in Connecticut.

Authors:  E D Shapiro; R Austrian
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

7.  Epidemiology of invasive pneumococcal infections in children in Finland.

Authors:  J Eskola; A K Takala; E Kela; E Pekkanen; R Kalliokoski; M Leinonen
Journal:  JAMA       Date:  1992-12-16       Impact factor: 56.272

8.  Clinical and epidemiologic studies of pneumococcal infection in children.

Authors:  B M Gray; H C Dillon
Journal:  Pediatr Infect Dis       Date:  1986 Mar-Apr

9.  Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987.

Authors:  S V Nielsen; J Henrichsen
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

Review 10.  Capsular types and susceptibility to penicillin of pneumococci isolated from cerebrospinal fluid or blood in Denmark, 1983-1988.

Authors:  S V Nielsen; J Henrichsen
Journal:  Scand J Infect Dis       Date:  1993
View more
  13 in total

Review 1.  New pneumococcal vaccines for children.

Authors:  S Choo; A Finn
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

Review 2.  Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996).

Authors:  A Fenoll; I Jado; D Vicioso; A Pérez; J Casal
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

3.  Burden of paediatric invasive pneumococcal disease in Europe, 2005.

Authors:  E D G McIntosh; B Fritzell; M A Fletcher
Journal:  Epidemiol Infect       Date:  2006-09-07       Impact factor: 2.451

Review 4.  Epidemiology of pneumococcal infections in the elderly.

Authors:  J C Butler; A Schuchat
Journal:  Drugs Aging       Date:  1999       Impact factor: 3.923

Review 5.  Pneumococcal vaccine in the elderly: the Norwegian experience.

Authors:  I S Aaberge
Journal:  Drugs Aging       Date:  1999       Impact factor: 3.923

Review 6.  Pneumococcal vaccination and revaccination of older adults.

Authors:  Andrew S Artz; William B Ershler; Dan L Longo
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

7.  Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001.

Authors:  Ralf René Reinert; Rudolf Lütticken; André Bryskier; Adnan Al-Lahham
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya.

Authors:  Catherine Laine; Tabitha Mwangi; Claudette M Thompson; Jacktone Obiero; Marc Lipsitch; J Anthony G Scott
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

9.  Pneumococcal infections in humans are associated with increased apoptosis and trafficking of type 1 cytokine-producing T cells.

Authors:  Kåre Kemp; Helle Bruunsgaard; Peter Skinhøj; Bente Klarlund Pedersen
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

10.  Bacteremia with Streptococcus pneumoniae: sepsis and other risk factors for 30-day mortality--a hospital-based cohort study.

Authors:  J S Christensen; T G Jensen; H J Kolmos; C Pedersen; A Lassen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-13       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.